^
Association details:
| Biomarker: | HLA-A*11 |
|---|---|
| Cancer: | Solid Tumor |
| Drug Class: | Immunotherapy |
| Direction: | Sensitive |
Evidence:
Source:
Title:
184P - Patient-specific HLA-I genotypes predict response to immune checkpoint blockade
Published date:
10/16/2023
Excerpt:
In the other cancers subgroup, HLA-A11 and A24 were associated with better OS (HR: 0.20, 95%CI: 0.05-0.85, p= 0.030 and HR: 0.31, 95% CI: 0.10-0.89, p= 0.029, respectively).
